Virtus Biotech Clinical Trials ETF
11 hedge funds and large institutions have $1.71M invested in Virtus Biotech Clinical Trials ETF in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9.43% more ownership
Funds ownership: 6.7% → 16.13% (+9.4%)
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$785K | |
| 2 | +$204K | |
| 3 | +$202K | |
| 4 |
LPL Financial
San Diego,
California
|
+$10.6K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.5K |